Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Fidelity Disruptive Medicine ETF (FMED) belongs to the Multiple Trends segment. Invesco Nasdaq Biotechnology ETF (IBBQ) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. FMED is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.19% for IBBQ. FMED is down -10.31% year-to-date (YTD) with - in YTD flows. IBBQ performs better with -0.7% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of FMED and IBBQ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FMED IBBQ | -6.92%-5.53% | -10.09%+1.14% | -10.31%-0.70% | -0.32%+28.29% | n/a+43.75% | n/an/a |
| Flows | FMED IBBQ | -- | -+$11M | -+$8M | +$5M+$21M | -+$47M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FMED IBBQ | +19.28%+21.07% | +19.99%+23.16% | n/a+19.31% | n/an/a |
| Max drawdown | FMED IBBQ | -14.72%-6.55% | -15.97%-17.05% | n/a-23.78% | n/an/a |
| Max drawdown duration | FMED IBBQ | 55d22d | 108d120d | n/a375d | n/an/a |
FMED | IBBQ | |
Last sale 3/18/2026 at 1:30 PM | $24.30 | $28.18 |
| Previous close 03/18/2026 | $24.77 | $28.75 |
| Consolidated volume 03/18/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FMED | IBBQ | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FMED | IBBQ | |
|---|---|---|
| Last price | $24.30 | $28.18 |
| 1D performance | -1.91% | -1.98% |
| AuM | $56.47 M | $71.02 M |
| E/R | 0.5% | 0.19% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
